Table 1 Baseline patient characteristics

Age, year

64

59–69

BMI, kg/m2

24.5

22.4–26.1

Comorbidity

N

%

 Hypertension

92

43.2

 DM

27

12.7

PSA level, ng/ml

5.35

4.0–7.5

Prostate volume, ml

31.2

23.2–41.2

Follow up period after RP, months

51

32–70

Tumor volume at specimen, cc

0.6

0.2–1.4

Biopsy Gleason score

N

%

 6

162

76.1

 7

37

17.4

  ≥ 8

14

6.6

Pathologic Gleason score

N

%

 6

115

54

 7

78

36.6

  ≥ 8

20

9.4

Pathologic T stage

N

%

  ≤ T2

185

86.9

  ≥ T3

28

13.1

ECE

N

%

28

13.1

SVI

N

%

1

0.5

PSM(R1)

N

%

18

8.5

LVI

N

%

3

1.4

PNI

N

%

63

29.6

BCR

N

%

29

13.6